Below are the financial statements of Transmedics Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | — | — | — |
| Net product revenue | 273.87a | 176.07a | 79.23a |
| Service revenue | 167.67a | 65.55a | 14.23a |
| Total revenue | 441.54a | 241.62a | 93.46a |
| Cost of revenue | — | — | — |
| Cost of net product revenue | -58.35a | -41.02a | -16.97a |
| Cost of service revenue | -121.11a | -46.52a | -11.22a |
| Total cost of revenue | -179.46a | -87.53a | -28.19a |
| Gross profit | 262.08a | 154.09a | 65.27a |
| Operating expenses | — | — | — |
| Research, development and clinical trials | -55.97a | -36.06a | -26.81a |
| Acquired in-process research and development expenses | 0a | -27.21a | 0a |
| Selling, general and administrative | -168.62a | -119.55a | -69.9a |
| Total operating expenses | -224.59a | -182.82a | -96.71a |
| Income (loss) from operations | 37.5a | -28.73a | -31.44a |
| Other income (expense) | — | — | — |
| Interest expense | -14.41a | -10.79a | -3.73a |
| Interest income and other income (expense), net | 12.69a | 12.85a | -1a |
| Total other income (expense), net | -1.72a | 2.06a | -4.73a |
| Income (loss) before income taxes | 35.78a | -26.67a | -36.17a |
| (Provision) benefit for income taxes | -0.32a | -1.64a | -0.07a |
| Net income (loss) | 35.46a | -25.03a | -36.23a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Transmedics Group’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.